ArticleBMJ global health2025

Long COVID prevalence and risk factors in adults residing in middle- and high-income countries: secondary analysis of the multinational Anti-Coronavirus Therapies (ACT) trials.

Lucas Etienne Hermans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.